Skip to content
HowShorted

DermTech, Inc. short interest in 2023

In 2023, DermTech, Inc.'s disclosed short interest ran from 8.47% of shares outstanding on 13 Jan 2023 to 8.92% on 29 Dec 2023, a change of +0.45 percentage points. The year's high was 16.69% on 30 Nov 2023 and its low 8.31% on 15 Feb 2023, averaging 11.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.75 days on 31 Aug 2023. Full history: DermTech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for DermTech, Inc. in 2023

2023 in figures

Start of year
8.47% (13 Jan 2023)
End of year
8.92% (29 Dec 2023)
Change
+0.45 pp
High
16.69% (30 Nov 2023)
Low
8.31% (15 Feb 2023)
Average
11.67%
Highest days to cover
31.75 (31 Aug 2023)
SEC filings marked
8

Every report in 2023

DermTech, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20238.47%1.76
31 Jan 20238.63%2.20
15 Feb 20238.31%4.48
28 Feb 202310.31%5.67
15 Mar 202310.59%7.0310-K filed, results (8-K)
31 Mar 202311.31%13.14
14 Apr 202310.56%10.99
28 Apr 202310.23%9.08
15 May 20239.37%4.0010-Q filed, results (8-K)
31 May 20239.09%10.83
15 Jun 202310.40%6.98
30 Jun 202311.70%8.59
14 Jul 202312.48%12.72
31 Jul 202312.07%13.01
15 Aug 202313.01%14.7610-Q filed, results (8-K)
31 Aug 202314.31%31.75
15 Sep 202314.02%19.41
29 Sep 202314.50%20.91
13 Oct 202315.53%15.99
31 Oct 202315.07%24.26
15 Nov 202315.68%16.7210-Q filed, results (8-K)
30 Nov 202316.69%28.87
15 Dec 20238.72%3.91
29 Dec 20238.92%4.29

See also: DermTech, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.